These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39193691)

  • 41. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy.
    Kiszewski AE; De Villa D; Scheibel I; Ricachnevsky N
    Pediatr Dermatol; 2009; 26(1):105-6. PubMed ID: 19250426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.
    Adışen E; Özer İ; Temel B; Gürer MA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
    Dalaker M; Bonesrønning JH
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225
    [No Abstract]   [Full Text] [Related]  

  • 44. Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau.
    Rubio C; Martin MA; Arranz Sánchez DM; Vidaurrazaga C; Casado M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):707-8. PubMed ID: 18785890
    [No Abstract]   [Full Text] [Related]  

  • 45. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
    Iijima S; Okazaki Y; Watanabe S; Maruyama Y
    J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three years' experience with infliximab in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Clin Exp Dermatol; 2006 Sep; 31(5):630-3. PubMed ID: 16901301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of TNF blockers and of ustekinumab in palmoplantar pustulosis and in acrodermatitis continua of Hallopeau.
    Husson B; Barbe C; Hegazy S; Seneschal J; Aubin F; Mahé E; Jullien D; Sbidian E; D'Incan M; Conrad C; Brenaut E; Girard C; Richard MA; Bachelez H; Viguier M;
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2330-2338. PubMed ID: 32030802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab.
    Herrero-Moyano M; Capusan TM; Martínez-Mera C; Llamas-Velasco M; Daudén E
    JAAD Case Rep; 2018 Sep; 4(8):842-844. PubMed ID: 30246137
    [No Abstract]   [Full Text] [Related]  

  • 49. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
    Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
    Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
    Wang Y; Zhang L; Zheng J; Li X; Chen L
    JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case of acrodermatitis continua accompanied by psoriatic arthritis.
    Jo SJ; Park JY; Yoon HS; Youn JI
    J Dermatol; 2006 Nov; 33(11):787-91. PubMed ID: 17073995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment of sub-erythrodermic psoriasis with bimekizumab: a case report and literature review.
    Licata G; Rizzo D; Frazzitta M; Zichichi L
    Int J Dermatol; 2024 Aug; 63(8):1105-1107. PubMed ID: 38736089
    [No Abstract]   [Full Text] [Related]  

  • 53. Acrodermatitis continua of hallopeau successfully treated with adalimumab.
    Sopkovich JA; Anetakis Poulos G; Wong HK
    J Clin Aesthet Dermatol; 2012 Feb; 5(2):60-2. PubMed ID: 22468174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: A retrospective analysis of 66 cases in a single center in Taiwan.
    Huang CM; Tsai TF
    J Dermatol; 2020 Sep; 47(9):1046-1049. PubMed ID: 32613680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
    Bardazzi F; Di Altobrando A; Lacava R
    Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
    [No Abstract]   [Full Text] [Related]  

  • 56. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar.
    Megna M; Fabbrocini G; Costa C; Ferrillo M
    Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123
    [No Abstract]   [Full Text] [Related]  

  • 57. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
    Zhang Z; Wu X; Han C; Chen M; Liu Y
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
    [No Abstract]   [Full Text] [Related]  

  • 58. Acrodermatitis continua of Hallopeau: evolution of treatment options.
    Sehgal VN; Verma P; Sharma S; Srivastava G; Aggarwal AK; Rasool F; Chatterjee K
    Int J Dermatol; 2011 Oct; 50(10):1195-211. PubMed ID: 21950286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronically painful right thumb with pustules and onycholysis. Diagnosis: acrodermatitis continua of Hallopeau.
    Waller JM; Wu JJ; Murase JE; Dyson SW; Kelly KM
    Clin Exp Dermatol; 2007 Sep; 32(5):619-20. PubMed ID: 17501968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.